JO
CRXT

John Overdeck’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

John Overdeck’s Portfolio CRXT Stock Details CRXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,001
Closed -$4K – 2998
2022
Q2 		$4K Buy
+10,001
New +$7K ﹤0.01% 2440

Other funds holding CRXT

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

John Overdeck's CRXT Position: Q3 2022 in Review

John Overdeck sold out of Clarus Therapeutics Holdings, Inc. Common Stock (CRXT) in Q3 2022, closing a stake of 10,001 shares — an estimated $4K sold.

John Overdeck first reported a position in CRXT in Q2 2022 and held it in 1 quarter. The position peaked at $4K in Q2 2022. 2 funds tracked by Wall St. Rank hold CRXT as of Q3 2022.

  • John Overdeck reported no remaining Clarus Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • John Overdeck sold 10,001 Clarus Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $4K.
  • John Overdeck first reported a position in Clarus Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • John Overdeck's Clarus Therapeutics Holdings, Inc. Common Stock position peaked at $4K in Q2 2022.
  • 2 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.